"/> Novus Biologicals™ Peptide bloquant d’anticorps BRE | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps BRE

Réf. : BL-RE-081671Réf. fabricant : 18258095 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
9577
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76830. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 18 amino acids near the amino terminus of human BRCC45.

Points forts

Source

Synthetic

(Accession #: NP_004890) The BRE Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-081671
Réf. fabricant18258095
Gene ID (Entrez)9577
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76830. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènebrain and reproductive organ-expressed (TNFRSF1A modulator), BRCA1/BRCA2-containing complex subunit 45, subunit 4
Symbole de gène(s)BABAM2
Type de produitBRE
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne18 amino acids near the amino terminus of human BRCC45
Une question, une configuration particulière ?
Contactez-nous pour un devis.